Crossmark

Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study

Crossref DOI link: https://doi.org/10.1007/s00198-014-2871-6

Published Online: 2014-09-19

Published Print: 2015-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Silverman, S. L.

Siris, E.

Kendler, D. L.

Belazi, D.

Brown, J. P.

Gold, D. T.

Lewiecki, E. M.

Papaioannou, A.

Simonelli, C.

Ferreira, I.

Balasubramanian, A.

Dakin, P.

Ho, P.

Siddhanti, S.

Stolshek, B.

Recknor, C.
License Information

License valid from 2014-09-19